Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 5.4%

Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) traded down 5.4% on Monday . The company traded as low as $16.90 and last traded at $16.91. 34,210 shares traded hands during trading, a decline of 84% from the average session volume of 212,303 shares. The stock had previously closed at $17.87.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Pulse Biosciences to a “sell” rating in a research note on Friday.

Pulse Biosciences Price Performance

The stock has a market cap of $956.50 million, a price-to-earnings ratio of -20.75 and a beta of 1.75. The business’s 50 day moving average is $17.63 and its 200 day moving average is $12.65.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in Pulse Biosciences by 28.8% in the first quarter. Vanguard Group Inc. now owns 847,212 shares of the company’s stock valued at $7,379,000 after purchasing an additional 189,227 shares in the last quarter. Cetera Advisors LLC purchased a new position in shares of Pulse Biosciences in the 1st quarter valued at $109,000. BNP Paribas Financial Markets grew its position in shares of Pulse Biosciences by 63.6% in the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after buying an additional 2,952 shares during the last quarter. PNC Financial Services Group Inc. acquired a new stake in Pulse Biosciences during the 4th quarter worth $242,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in shares of Pulse Biosciences during the first quarter worth about $88,000. 76.95% of the stock is owned by institutional investors and hedge funds.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.